4
Changes in Ownership
KIORA PHARMACEUTICALS INC Filed Acc 0001144204-16-096682
Options or other derivatives
- Chief Financial Officer acquired 41,732 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Brenneman Ryan Randall · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-04-25 | Grant or award : show line 1 in the form Stock Option (right to buy) | +41,732 | $3.23 | 2026-04-25 | 41,732 | 41,732 | D |
Loading xslF345X03/v438134_4.xml…